10429-30-8 Usage
Uses
Used in Pharmaceutical Industry:
2-(3-DIMETHYLAMINO-PROPOXY)-BENZALDEHYDE is utilized as an intermediate in the synthesis of various pharmaceuticals. Its unique structure allows it to be a key component in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Organic Compounds Synthesis:
2-(3-DIMETHYLAMINO-PROPOXY)-BENZALDEHYDE serves as an essential intermediate in the synthesis of organic compounds, enabling the creation of a wide range of chemical products with diverse applications.
Used in Dye Production:
2-(3-DIMETHYLAMINO-PROPOXY)-BENZALDEHYDE is employed in the production of dyes, where its chemical properties contribute to the development of new colorants for various applications, including textiles, plastics, and printing inks.
Used in Chemical Product Manufacturing:
Beyond pharmaceuticals and dyes, 2-(3-DIMETHYLAMINO-PROPOXY)-BENZALDEHYDE has potential applications in the broader chemical product manufacturing industry, where it can be used to produce a variety of chemical products with specific properties and functions.
It is crucial to handle 2-(3-DIMETHYLAMINO-PROPOXY)-BENZALDEHYDE with care due to its potential hazards to human health and the environment if not properly managed. Proper safety measures and disposal methods should be implemented to mitigate any risks associated with its use.
Check Digit Verification of cas no
The CAS Registry Mumber 10429-30-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,4,2 and 9 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 10429-30:
(7*1)+(6*0)+(5*4)+(4*2)+(3*9)+(2*3)+(1*0)=68
68 % 10 = 8
So 10429-30-8 is a valid CAS Registry Number.
InChI:InChI=1/C12H17NO2/c1-13(2)8-5-9-15-12-7-4-3-6-11(12)10-14/h3-4,6-7,10H,5,8-9H2,1-2H3
10429-30-8Relevant academic research and scientific papers
IMIDAZO [2, 1-F] [1, 2, 4] TRIAZIN-4-AMINE DERIVATIVES AS TLR7 AGONIST
-
Paragraph 0327-0328, (2020/08/22)
Disclosed herein is an imidazo [2, 1-f] [1, 2, 4] triazin-4-amine derivative or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof useful as a TLR7 agonist, and a pharmaceutical composition comprising the same. Also disclosed herein is a method of treating cancer using the imidazo [2, 1-f] [1, 2, 4] triazin-4-amine derivative or a stereoisomer thereof, or a pharmaceutically acceptable salt thereof as TLR7 agonist.
